Preterm Infants Fed Prolacta’s 100% Human Milk-Based Fortifiers Achieved Catch-Up Growth by Age 2 with Appropriate Neurodevelopmental Outcomes, Study Says
Retrieved on:
Monday, June 1, 2020
Authored by Erynn M. Bergner, M.D., and colleagues, the new study2 is the first to concurrently evaluate long-term neurodevelopmental, growth, and body composition outcomes of preterm infants in the neonatal intensive care unit (NICU).
Key Points:
- Authored by Erynn M. Bergner, M.D., and colleagues, the new study2 is the first to concurrently evaluate long-term neurodevelopmental, growth, and body composition outcomes of preterm infants in the neonatal intensive care unit (NICU).
- Researchers found:
Preterm infants receiving Prolactas 100% human milk-based fortifiers returned to birth z-scores for weight, length, and head circumference by age 2. - A similar percentage of body fat and lean mass in preterm infants at age 2, compared to matched term controls, with adequate bone mineralization.
- Bergner et al2 evaluated the post-discharge growth, body composition, and neurodevelopmental outcomes of a cohort of infants 1,250 g birth weight who received Prolactas fortifiers as part of an EHMD in the NICU.